Chia Tai Enterprises International Limited (HKG:3839)
6.75
+0.03 (0.45%)
At close: Feb 13, 2026
HKG:3839 Revenue
Chia Tai Enterprises International had revenue of $107.21M USD in the quarter ending September 30, 2025, with 71.31% growth. This brings the company's revenue in the last twelve months to $567.72M, up 154.57% year-over-year. In the year 2024, Chia Tai Enterprises International had annual revenue of $307.75M with 76.89% growth.
Revenue (ttm)
$567.72M
Revenue Growth
+154.57%
P/S Ratio
0.37
Revenue / Employee
$630.80K
Employees
900
Market Cap
1.62B HKD
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 307.75M | 133.77M | 76.89% |
| Dec 31, 2023 | 173.98M | 14.74M | 9.26% |
| Dec 31, 2022 | 159.24M | 16.83M | 11.82% |
| Dec 31, 2021 | 142.41M | 48.83M | 52.18% |
| Dec 31, 2020 | 93.58M | -11.47M | -10.91% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Essex Bio-Technology | 1.72B |
| Jacobson Pharma Corporation | 1.53B |
| Lee's Pharmaceutical Holdings | 1.44B |
| Dawnrays Pharmaceutical (Holdings) | 1.22B |
| Golden Throat Holdings Group Company | 1.07B |
| Jilin Province Huinan Changlong Bio-pharmacy Company | 1.02B |
| JBM (Healthcare) | 812.98M |
| Hua Medicine (Shanghai) | 406.16M |